product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
SEK1 (5C10) Rabbit mAb
catalog :
3346
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
5c10
reactivity :
human, mouse, rat, dog
application :
western blot, immunoprecipitation
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; loading ...; fig 6b
Farsam V, Basu A, Gatzka M, Treiber N, Schneider L, Mulaw M, et al. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration. Oncotarget. 2016;7:83554-83569 pubmed publisher
Tegnebratt T, Ruge E, Bader S, Ishii N, Aida S, Yoshimura Y, et al. Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches. EJNMMI Res. 2014;4:34 pubmed publisher
Lew B, Cho Y, Kim J, Sim W, Kim N. Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-alpha, and JNK. J Korean Med Sci. 2006;21:95-9 pubmed
product information
SKU :
3346S
Product-Name :
SEK1 (5C10) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk, (Dg)
Applications :
Immunoprecipitation
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
44
Host :
Rabbit
Target :
MKK4
Primary-Protein :
MKK4
Alt-Names :
Dual specificity mitogen-activated protein kinase kinase 4,JNK activating kinase 1,JNK-activated kinase 1,JNK-activating kinase 1,JNKK,JNKK1,MAP kinase kinase 4,MAP2K4,MAPK/ERK kinase 4,MAPKK 4,MAPKK4,MEK 4,MEK4,MKK4,MP2K4,PRKMK4,SAPK/ERK kinase 1,SEK1,SERK1,c-Jun N-terminal kinase kinase 1,mitogen-activated protein kinase kinase 4
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.